| Name | 3-[18-(2-carboxylatoethyl)-8,13-diethyl-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoate,hydron,tin(4+),dichloride |
|---|---|
| Synonyms |
tin mesoporphyrin IX dichloride
Tin mesoporphyrin Sn Mesoporphyrin Stannsoporfin SNMPP Stanate |
| Description | Tin(IV) mesoporphyrin IX dichloride (Stannsoporfin) is a heme oxygenase (HO) inhibitor being developed for the prevention of hyperbilirubinemia in infants at risk of developing jaundice, extracted from patent WO2011103196A1[1]. |
|---|---|
| Related Catalog | |
| Target |
HO[1] |
| References |
| Boiling Point | 1096.1ºC at 760mmHg |
|---|---|
| Molecular Formula | C34H36Cl2N4O4Sn |
| Molecular Weight | 754.28100 |
| Flash Point | 616.7ºC |
| Exact Mass | 754.11400 |
| PSA | 130.76000 |
| LogP | 1.88710 |
| Vapour Pressure | 0mmHg at 25°C |
|
~95%
106344-20-1 |
| Literature: BOUCHER, Christopher P.; ROE, David Patent: US2012/253033 A1, 2012 ; Location in patent: Page/Page column 6 ; |
|
~%
106344-20-1 |
| Literature: US2012/253033 A1, ; Page/Page column 8-9 ; |
| Precursor 2 | |
|---|---|
| DownStream 0 | |